title: A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer.
authors.affiliation: Department of Obstetrics and Gynaecology, Friedrich Alexander University, Erlangen, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Jager
authors.forename: W
authors.initials: W
authors.lastname: Sauerbrei
authors.forename: E
authors.initials: E
authors.lastname: Beck
authors.forename: V
authors.initials: V
authors.lastname: Maassen
authors.forename: M
authors.initials: M
authors.lastname: Stumpfe
authors.forename: W
authors.initials: W
authors.lastname: Meier
authors.forename: W
authors.initials: W
authors.lastname: Kuhn
authors.forename: F
authors.initials: F
authors.lastname: Janicke
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D018284:Cystadenocarcinoma, Serous / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D018450:Disease Progression; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D016879:Salvage Therapy; D015996:Survival Rate; D013629:Tamoxifen / Q000627:therapeutic use*; D017211:Treatment Failure; D017329:Triptorelin Pamoate / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D017329:Triptorelin Pamoate; D013629:Tamoxifen; D007987:Gonadotropin-Releasing Hormone